Skip to main content

Vistin Pharma ASA: Change in oil derivative exposure

Written by Customer Service on . Posted in Public Companies.

Oslo, Norway, 28 February 2020
Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN), announces that the company has reduced its exposure to the spread between ICE low sulphur gasoil and Sing380.The changed exposure has been carried out by reducing the position in ICE low sulphur gasoil with 5,000MT in April and 25,000MT in December while keeping the exposure to the SING380 unchanged.The transaction has been carried out to reduce the remaining overall risk in the portfolio of oil derivatives under the current market conditions.The transaction resulted in a loss of approximately 46.5 million. 
                       
After the transactions, excluding the contracts that expire in February, the remaining positions are long in the spread between Gasoil versus Sing380 with 47,600MT and short on Sing380 with 30,000MT:As previously communicated, any changes to the volumes and exposure will be subsequently announced. *****For further information, please contact:Lars Christian Stugaard+47 47 63 05 22
LarsChristian@ferncliff.noThis information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.